Michel Orsinger, Board of Directors - Takeda Pharmaceuticals
Profile Section
Michel Orsinger
External Director
Mar 2001 - Chief Executive Officer and President, OTC Division Worldwide, Consumer Health, Novartis AG
Apr 2007 - President and Chief Executive Officer, Synthes, Inc. (currently Johnson & Johnson)
Jun 2012 - Worldwide Chairman, Global Orthopedics Group, DePuy Synthes Companies, Johnson & Johnson
Jun 2012 - Member of Global Management Team, Johnson & Johnson
Jun 2016 - External Director of the Company
Jun 2019 - External Director of the Company who is an ASC Member
Jun 2022 - External Director of the Company (to present)